POSEIDA Trademark

Trademark Overview

On Wednesday, April 21, 2021, a trademark application was filed for POSEIDA with the United States Patent and Trademark Office. The USPTO has given the POSEIDA trademark a serial number of 90660245. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Wednesday, September 11, 2024. This trademark is owned by Poseida Therapeutics, Inc.. The POSEIDA trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for use in medical and clinical cell therapy; gene therapy products, namely, engineered cells and engineered cell platforms for medical or clinical use
poseida

General Information

Serial Number90660245
Word MarkPOSEIDA
Filing DateWednesday, April 21, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateWednesday, September 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 25, 2022

Trademark Statements

Goods and ServicesBiological preparations for use in medical and clinical cell therapy; gene therapy products, namely, engineered cells and engineered cell platforms for medical or clinical use
Translation of Words in MarkThe English translation of the word “poseida” in the mark is “possessed”.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 28, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePoseida Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NamePoseida Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Saturday, April 24, 2021NEW APPLICATION ENTERED
Wednesday, July 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 15, 2021ASSIGNED TO EXAMINER
Friday, December 17, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, December 17, 2021EXAMINERS AMENDMENT E-MAILED
Friday, December 17, 2021EXAMINERS AMENDMENT -WRITTEN
Friday, December 17, 2021EXAMINER'S AMENDMENT ENTERED
Sunday, December 19, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, January 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 25, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 22, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 22, 2022SOU TEAS EXTENSION RECEIVED
Thursday, September 22, 2022SOU EXTENSION 1 FILED
Thursday, September 22, 2022SOU EXTENSION 1 GRANTED
Saturday, February 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, September 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 23, 2023SOU TEAS EXTENSION RECEIVED
Thursday, February 23, 2023SOU EXTENSION 2 FILED
Thursday, February 23, 2023SOU EXTENSION 2 GRANTED
Wednesday, August 16, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 16, 2023SOU EXTENSION 3 FILED
Wednesday, August 16, 2023SOU EXTENSION 3 GRANTED
Friday, August 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 12, 2024SOU EXTENSION 4 FILED
Tuesday, March 12, 2024SOU EXTENSION 4 GRANTED
Wednesday, March 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 11, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 11, 2024SOU EXTENSION 5 GRANTED
Wednesday, September 11, 2024SOU EXTENSION 5 FILED
Wednesday, September 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 12, 2024SOU TEAS EXTENSION RECEIVED

Related Keywords

poseida cell engineered clinical therapy medical cells platforms preparations products biological